This pathway has been previously implicated in psychiatric conditions such as schizophrenia and anxiety through one of its key effectors, the “Nitric Oxide Synthase 1 Adaptor Protein” (NOS1AP). This evidence concerns the gene NOS1AP and schizophrenia.